Teriparatide

Trade Name: 
Osnuvo
Manufacturer/Distributor: 
AVIR Pharma Inc.
Classification: 
Bone formation agent
ATC Class: 
H05AA02 - teriparatide
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2020/01/13
Date Marketed in Canada (yyyy/mm/dd): 
2020/10/27
Presentation: 
Solution for S/C injection: 250 mcg/mL. DIN: 02495589
Comments: 
For treatment of postmenopausal women with severe osteoporosis; to increase bone mass in men with severe osteoporosis; for treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in men and women who are at increased risk for fracture.
Source: 
Product monograph